Literature DB >> 16885053

Clinical features and outcome of familial chronic lymphocytic leukemia.

Francesca R Mauro1, Elena Giammartini, Massimo Gentile, Isabella Sperduti, Veronica Valle, Antonio Pizzuti, Anna Guarini, Diana Giannarelli, Robin Foà.   

Abstract

The prognostic impact of the presence of a familial trait was analyzed in 1449 patient with chronic lymphocytic leukemia (CLL). A family history of hematologic malignancy (HM) was identified in 181 cases (12.5%) and recorded more frequently among female than male patients (HM: p < 0.05; CLL: p < 0.05). The relative was affected by CLL in 89 cases (6%). Familial and sporadic cases showed non-statistically different proportions of advanced stages (10.8 vs 7.1%) and patients requiring therapy (55 vs 60%) and a similar survival probability at 10 years (67 vs 66%). These data suggest that in CLL the presence of a familial trait does not imply an adverse prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16885053

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  15 in total

1.  Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.

Authors:  Lynn R Goldin; Ola Landgren; Gerald E Marti; Neil E Caporaso
Journal:  European J Clin Med Oncol       Date:  2010-02

2.  Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.

Authors:  Vilhjálmur Steingrímsson; Sigrún Helga Lund; Ingemar Turesson; Lynn R Goldin; Magnus Björkholm; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

Review 3.  Familial chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Susan L Slager; Neil E Caporaso
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

4.  Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility.

Authors:  Lynn R Goldin; Mary L McMaster; Melissa Rotunno; Sarah E M Herman; Kristine Jones; Bin Zhu; Joseph Boland; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Alisa M Goldstein; Stephen J Chanock; Margaret A Tucker; Adrian Wiestner; Gerald Marti; Neil E Caporaso
Journal:  Blood       Date:  2016-09-14       Impact factor: 22.113

5.  Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization.

Authors:  Sunita R Setlur; Chunhwa Ihm; Joelle Tchinda; Soheil Shams; Lillian Werner; Eun Kyung Cho; Christina Thompson; Kimberly Phillips; Laura Z Rassenti; Thomas J Kipps; Donna Neuberg; Arnold S Freedman; Charles Lee; Jennifer R Brown
Journal:  Br J Haematol       Date:  2010-08-31       Impact factor: 6.998

Review 6.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

Review 7.  Familial chronic lymphocytic leukemia: what does it mean to me?

Authors:  Susan L Slager; Neil E Kay
Journal:  Clin Lymphoma Myeloma       Date:  2009

8.  The molecular basis of familial chronic lymphocytic leukemia.

Authors:  Dalemari Crowther-Swanepoel; Richard S Houlston
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

9.  Survival patterns among lymphoma patients with a family history of lymphoma.

Authors:  Lesley A Anderson; Ruth M Pfeiffer; Joshua S Rapkin; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

10.  Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future.

Authors:  Jennifer R Brown
Journal:  Ther Adv Hematol       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.